Your browser doesn't support javascript.
loading
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Sehgal, Alison; Hoda, Daanish; Riedell, Peter A; Ghosh, Nilanjan; Hamadani, Mehdi; Hildebrandt, Gerhard C; Godwin, John E; Reagan, Patrick M; Wagner-Johnston, Nina; Essell, James; Nath, Rajneesh; Solomon, Scott R; Champion, Rebecca; Licitra, Edward; Fanning, Suzanne; Gupta, Neel; Dubowy, Ronald; D'Andrea, Aleco; Wang, Lei; Ogasawara, Ken; Thorpe, Jerill; Gordon, Leo I.
Afiliação
  • Sehgal A; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address: sehgalar@upmc.edu.
  • Hoda D; Intermountain Healthcare, LDS Hospital, Salt Lake City, UT, USA.
  • Riedell PA; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA.
  • Ghosh N; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Hamadani M; BMT and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Godwin JE; Providence Cancer Center, Earle A Chiles Research Institute, Portland, OR, USA.
  • Reagan PM; University of Rochester Medical Center, Rochester, NY, USA.
  • Wagner-Johnston N; Department of Oncology, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Essell J; Oncology Hematology Care, Cincinnati, OH, USA.
  • Nath R; Department of Stem Cell Transplant and Cellular Therapy, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Solomon SR; Transplant and Cellular Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA, USA.
  • Champion R; Hematologic Malignancies Program, Norton Cancer Institute, Louisville, KY, USA.
  • Licitra E; Astera Cancer Care, East Brunswick, NJ, USA.
  • Fanning S; Prisma Health, Greenville, SC, USA.
  • Gupta N; Stanford Cancer Genetics Clinic, Palo Alto, CA, USA.
  • Dubowy R; Bristol Myers Squibb, Seattle, WA, USA.
  • D'Andrea A; Celgene, a Bristol-Myers Squibb company, Boudry, Switzerland.
  • Wang L; Bristol Myers Squibb, Seattle, WA, USA.
  • Ogasawara K; Bristol Myers Squibb, Lawrence Township, NJ, USA.
  • Thorpe J; Bristol Myers Squibb, Seattle, WA, USA.
  • Gordon LI; Northwestern University, Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA.
Lancet Oncol ; 23(8): 1066-1077, 2022 08.
Article em En | MEDLINE | ID: mdl-35839786
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Linfoma Folicular / Linfoma Difuso de Grandes Células B / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Linfoma Folicular / Linfoma Difuso de Grandes Células B / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article